HassenKMaccaroniMRSabryHMukherjeeSSerumadarSBirdiI. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox) anticoagulation. Perfusion2018; 33: 235–240.
2.
ReedMDBellD.Clinical pharmacology of bivalirudin. Pharmacotherapy2002; 22: 105S–111S.
3.
RefaaiMAWarkentinTEAxelsonMMatevosyanKSarodeR.Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin “flushes”. Thromb Haemost2007; 98: 1139–1140.
4.
OstermannHHaertelSKnaubSKalinaUJungKPabingerI.Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers. Thromb Haemost2007; 98: 790–797.
5.
MajeedAEeldeAAgrenASchulmannSHolmströmM.Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res2012; 129: 146–151.
